Xiaohong Liu

机构：Beijing University of Posts and Telecommunications, Sichuan University, Hainan Maternal and Child Health Hospital, West China Hospital of Sichuan University, University College London · ORCID：0009-0006-4828-8017

发表论文 72 篇 · 总被引 1086 次 · h-index 18

代表论文

• Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial (2023 · The Lancet Oncology · 被引 208)
• LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment (2023 · Molecular Therapy · 被引 65)
• TCM-GPT: Efficient pre-training of large language models for domain adaptation in Traditional Chinese Medicine (2024 · Computer Methods and Programs in Biomedicine Update · 被引 51)
• The potential of large language models to advance precision oncology (2025 · EBioMedicine · 被引 28)
• Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway (2023 · Cancers · 被引 25)
• COVID ‐19 infection in patients with haematological malignancies: A single‐centre survey in the latest Omicron wave in China (2023 · British Journal of Haematology · 被引 15)